Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Early research (Phase 1)Study completedNCT01924260
What this trial is testing

Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+3 more
Edward Kim 26
Testing effectiveness (Phase 2)Study completedNCT03727880
What this trial is testing

Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Resectable Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Lei Zheng 28
Testing effectiveness (Phase 2)Study completedNCT00411762
What this trial is testing

A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Yale University 25
Testing effectiveness (Phase 2)Study completedNCT02420691
What this trial is testing

Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin

Who this might be right for
Advanced Digestive System Neuroendocrine NeoplasmDuodenal Neuroendocrine Tumor G1Functional Pancreatic Neuroendocrine Tumor+5 more
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT04371224
What this trial is testing

NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Seoul National University Hospital 200
Not applicableStudy completedNCT00826982
What this trial is testing

Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Mayo Clinic 90
Testing effectiveness (Phase 2)Study completedNCT01395017
What this trial is testing

Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Otsuka Pharmaceutical Development & Commercialization, Inc. 202
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07477418
What this trial is testing

PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Borderline Resectable Pancreatic CancerPancreatic Neoplasms
University of Vermont 10
Not applicableActive Not RecruitingNCT06291324
What this trial is testing

WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment

Who this might be right for
Pancreatic CancerBreast Cancer
Wake Forest University Health Sciences 46
Post-approval studies (Phase 4)Study completedNCT01525550
What this trial is testing

The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

Who this might be right for
Well-differentiated Pancreatic Neuroendocrine Tumor
Pfizer 106
Not applicableStudy completedNCT05722223
What this trial is testing

Trimodal Prehabilitation in Pancreatic Cancer Patients Urdergoing Neoadjuvant Treatment

Who this might be right for
Pancreatic Neoplasms
Puerta de Hierro University Hospital 14
Early research (Phase 1)Looking for participantsNCT05262491
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor

Who this might be right for
Gastrointestinal Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 96
Large-scale testing (Phase 3)UnknownNCT03398291
What this trial is testing

Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy

Who this might be right for
Pancreatic CancerLiver MetastasesSurgery
Fudan University 300
Not applicableStudy completedNCT03001518
What this trial is testing

Immunologic Signatures Following Surgery for Pancreatic Cancer

Who this might be right for
Pancreatic CancerSurgery
Duke University 33
Not applicableUnknownNCT05549960
What this trial is testing

Pre-planning Mathematical Models in EUS-guided Laser Ablation of Pancreatic Lesions

Who this might be right for
Pancreatic Neoplasms
Campus Bio-Medico University 10
Not applicableUnknownNCT03460925
What this trial is testing

Improving REsectability in Pancreatic NEoplasms (IRENE)

Who this might be right for
Pancreatic CancerStereotactic Body Radiotherapy
IRCCS Azienda Ospedaliero-Universitaria di Bologna 14
Very early researchWithdrawnNCT04123574
What this trial is testing

A Pilot Study of BXCL701 in Patients With Pancreatic Cancer

Who this might be right for
Cancer of PancreasCancer of the PancreasNeoplasms, Pancreatic+2 more
BioXcel Therapeutics Inc
Early research (Phase 1)Study completedNCT00266097
What this trial is testing

Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 23
Not applicableWithdrawnNCT03337997
What this trial is testing

A Pilot Study of IRE for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Resectable
University of Saskatchewan
Next Page